299 related articles for article (PubMed ID: 3001110)
1. Regulation of the epidermal growth factor receptor by phosphorylation.
Bertics PJ; Weber W; Cochet C; Gill GN
J Cell Biochem; 1985; 29(3):195-208. PubMed ID: 3001110
[TBL] [Abstract][Full Text] [Related]
2. Design and synthesis of novel tyrosine kinase inhibitors using a pharmacophore model of the ATP-binding site of the EGF-R.
Traxler P; Furet P; Mett H; Buchdunger E; Meyer T; Lydon N
J Pharm Belg; 1997; 52(2):88-96. PubMed ID: 9193132
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of epidermal growth factor receptor tyrosine kinase activity in A431 human epidermoid cells following psoralen/ultraviolet light treatment.
Mermelstein FH; Abidi TF; Laskin JD
Mol Pharmacol; 1989 Dec; 36(6):848-55. PubMed ID: 2557535
[TBL] [Abstract][Full Text] [Related]
4. Kinetics of activation of the tyrosine kinase of a deletion mutant of epidermal growth factor receptor missing the sites of self-phosphorylation.
Sherrill JM; Kyte J
Biochemistry; 1999 Mar; 38(10):3106-11. PubMed ID: 10074364
[TBL] [Abstract][Full Text] [Related]
5. The protein kinase C inhibitor Go6976 [12-(2-cyanoethyl)-6,7,12,13-tetrahydro-13-methyl-5-oxo-5H-indolo(2,3-a)pyrrolo(3,4-c)-carbazole] potentiates agonist-induced mitogen-activated protein kinase activation through tyrosine phosphorylation of the epidermal growth factor receptor.
Shah BH; Olivares-Reyes JA; Catt KJ
Mol Pharmacol; 2005 Jan; 67(1):184-94. PubMed ID: 15465928
[TBL] [Abstract][Full Text] [Related]
6. Epidermal growth factor-receptor-protein kinase interactions.
Cohen S; Carpenter G; King L
Prog Clin Biol Res; 1981; 66 Pt A():557-67. PubMed ID: 6273929
[TBL] [Abstract][Full Text] [Related]
7. Modulation of tyrosine, serine, and threonine phosphorylation and intracellular processing of the epidermal growth factor receptor by antireceptor monoclonal antibody.
Sunada H; Yu P; Peacock JS; Mendelsohn J
J Cell Physiol; 1990 Feb; 142(2):284-92. PubMed ID: 1689318
[TBL] [Abstract][Full Text] [Related]
8. Comparison of protein phosphorylations in variant A431 cells with different growth responses to epidermal growth factor.
Buss JE; Chouvet C; Gill GN
J Cell Physiol; 1984 Jun; 119(3):296-306. PubMed ID: 6202705
[TBL] [Abstract][Full Text] [Related]
9. Effect of epidermal growth factor and 12-O-tetradecanoylphorbol-13-acetate on the phosphorylation of soluble acidic proteins in A431 epidermoid carcinoma cells.
Sahai A; Feuerstein N; Cooper HL; Salomon DS
Cancer Res; 1986 Aug; 46(8):4143-50. PubMed ID: 3015383
[TBL] [Abstract][Full Text] [Related]
10. Modulation of the protein tyrosine kinase activity and autophosphorylation of the epidermal growth factor receptor by its juxtamembrane region.
Poppleton HM; Wiepz GJ; Bertics PJ; Patel TB
Arch Biochem Biophys; 1999 Mar; 363(2):227-36. PubMed ID: 10068444
[TBL] [Abstract][Full Text] [Related]
11. Regulation of the epidermal growth factor receptor by growth-modulating agents: effects of staurosporine, a protein kinase inhibitor.
Friedman B; Fujiki H; Rosner MR
Cancer Res; 1990 Feb; 50(3):533-8. PubMed ID: 1688732
[TBL] [Abstract][Full Text] [Related]
12. 4-(Phenylamino)pyrrolopyrimidines: potent and selective, ATP site directed inhibitors of the EGF-receptor protein tyrosine kinase.
Traxler PM; Furet P; Mett H; Buchdunger E; Meyer T; Lydon N
J Med Chem; 1996 Jun; 39(12):2285-92. PubMed ID: 8691423
[TBL] [Abstract][Full Text] [Related]
13. Tyrosine kinase inhibitors. 14. Structure-activity relationships for methylamino-substituted derivatives of 4-[(3-bromophenyl)amino]-6-(methylamino)-pyrido[3,4-d]pyrimidine (PD 158780), a potent and specific inhibitor of the tyrosine kinase activity of receptors for the EGF family of growth factors.
Rewcastle GW; Murray DK; Elliott WL; Fry DW; Howard CT; Nelson JM; Roberts BJ; Vincent PW; Showalter HD; Winters RT; Denny WA
J Med Chem; 1998 Feb; 41(5):742-51. PubMed ID: 9513602
[TBL] [Abstract][Full Text] [Related]
14. Cross talk of tumor necrosis factor-alpha and epidermal growth factor in human microvascular endothelial cells.
Izumi H; Ono M; Ushiro S; Kohno K; Kung HF; Kuwano M
Exp Cell Res; 1994 Oct; 214(2):654-62. PubMed ID: 7523156
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the epidermal growth factor receptor associated with cytoskeletons of A431 cells.
Roy LM; Gittinger CK; Landreth GE
J Cell Physiol; 1989 Aug; 140(2):295-304. PubMed ID: 2745564
[TBL] [Abstract][Full Text] [Related]
16. Phosphorylation of the epidermal growth factor receptor during internalization in A-431 cells.
Nesterov A; Lysan S; Vdovina I; Nikolsky N; Fujita DJ
Arch Biochem Biophys; 1994 Sep; 313(2):351-9. PubMed ID: 8080283
[TBL] [Abstract][Full Text] [Related]
17. Requirement for intrinsic protein tyrosine kinase in the immediate and late actions of the EGF receptor.
Chen WS; Lazar CS; Poenie M; Tsien RY; Gill GN; Rosenfeld MG
Nature; 1987 Aug 27-Sep 2; 328(6133):820-3. PubMed ID: 3498122
[TBL] [Abstract][Full Text] [Related]
18. Sporostatin, a novel and specific inhibitor of EGF receptor kinase.
Murakami Y; Ishii A; Mizuno S; Yaginuma S; Uehara Y
Anticancer Res; 1999; 19(5B):4145-9. PubMed ID: 10628366
[TBL] [Abstract][Full Text] [Related]
19. Epidermal growth factor receptor protein-tyrosine kinase activity in human cell lines established from squamous carcinomas of the head and neck.
Maxwell SA; Sacks PG; Gutterman JU; Gallick GE
Cancer Res; 1989 Mar; 49(5):1130-7. PubMed ID: 2783883
[TBL] [Abstract][Full Text] [Related]
20. Epidermal growth factor binding, stimulation of phosphorylation, and inhibition of gluconeogenesis in rat proximal tubule.
Harris RC; Daniel TO
J Cell Physiol; 1989 May; 139(2):383-91. PubMed ID: 2785525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
